NAII vs. IMRX, JSPR, PLRX, ZURA, SRZN, JMAC, PDSB, XBIT, IZTC, and IMUX
Should you be buying Natural Alternatives International stock or one of its competitors? The main competitors of Natural Alternatives International include Immuneering (IMRX), Jasper Therapeutics (JSPR), Pliant Therapeutics (PLRX), Zura Bio (ZURA), Surrozen (SRZN), Maxpro Capital Acquisition (JMAC), PDS Biotechnology (PDSB), XBiotech (XBIT), Invizyne Technologies (IZTC), and Immunic (IMUX). These companies are all part of the "pharmaceutical products" industry.
Natural Alternatives International vs. Its Competitors
Natural Alternatives International (NASDAQ:NAII) and Immuneering (NASDAQ:IMRX) are both small-cap medical companies, but which is the better business? We will compare the two companies based on the strength of their risk, community ranking, analyst recommendations, media sentiment, earnings, profitability, institutional ownership, dividends and valuation.
Natural Alternatives International received 237 more outperform votes than Immuneering when rated by MarketBeat users. Likewise, 77.07% of users gave Natural Alternatives International an outperform vote while only 71.19% of users gave Immuneering an outperform vote.
32.4% of Natural Alternatives International shares are held by institutional investors. Comparatively, 67.7% of Immuneering shares are held by institutional investors. 20.9% of Natural Alternatives International shares are held by insiders. Comparatively, 22.9% of Immuneering shares are held by insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a stock is poised for long-term growth.
Immuneering has a net margin of 0.00% compared to Natural Alternatives International's net margin of -6.56%. Natural Alternatives International's return on equity of -10.34% beat Immuneering's return on equity.
Immuneering has a consensus price target of $13.25, suggesting a potential upside of 443.03%. Given Immuneering's stronger consensus rating and higher possible upside, analysts clearly believe Immuneering is more favorable than Natural Alternatives International.
In the previous week, Immuneering had 23 more articles in the media than Natural Alternatives International. MarketBeat recorded 24 mentions for Immuneering and 1 mentions for Natural Alternatives International. Immuneering's average media sentiment score of 0.73 beat Natural Alternatives International's score of 0.00 indicating that Immuneering is being referred to more favorably in the news media.
Natural Alternatives International has higher revenue and earnings than Immuneering. Natural Alternatives International is trading at a lower price-to-earnings ratio than Immuneering, indicating that it is currently the more affordable of the two stocks.
Summary
Immuneering beats Natural Alternatives International on 10 of the 17 factors compared between the two stocks.
Get Natural Alternatives International News Delivered to You Automatically
Sign up to receive the latest news and ratings for NAII and its competitors with MarketBeat's FREE daily newsletter.
New MarketBeat Followers Over Time
This chart shows the number of new MarketBeat users adding NAII and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Media Sentiment Over Time
This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Natural Alternatives International Competitors List
Related Companies and Tools
This page (NASDAQ:NAII) was last updated on 6/24/2025 by MarketBeat.com Staff
Buy NAII Stock Free NAII Stock Alerts